Table 3.
TG concentration and cases with TG exceeding the upper limit of the norm: A. in individuals with abnormal versus normal results of thyroid function tests; B. in individuals treated versus not treated with glucocorticoids.
| Time point of observation | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||||||
| A | Parameter | Abnormal TFTs n=98 |
Normal TFTs n=62 |
p | Abnormal TFTs n=98 |
Normal TFTs n=48 |
p | Abnormal TFTs n=79 |
Normal TFTs n=23 |
p |
| TG (ng/ml), mean±SD | 42.6 ± 66.7 | 31.5 ± 26.9 | 0.365 | 32.3 ± 44.9 | 32.5 ± 46.4 | 0.305 | 26.2 ± 45.4 | 27.9 ± 23.2 | 0.864 | |
| TG>N, number of cases (%) |
11 (11.2) | 4 (6.5) | 0.313 | 10 (10.2) | 3 (6.1) | 0.545 | 4 (5.1) | 1 (4.3) | 1.000 | |
| B | GCG n=53 |
NGCG n=107 |
p | GCG n=68 |
NGCG n=77 |
p | GCG n=59 |
NGCG n=39 |
p | |
| TG (ng/ml), mean±SD | 38.1 ± 55.6 | 38.4 ± 55.0 | 0.787 | 25.2 ± 32.3 | 38.2 ± 53.8 | 0.033 | 21.3 ± 44.6 | 34.9 ± 37.2 | 0.001 | |
| TG>N, number of cases (%) |
5 (9.4) | 10 (9.3) | 1.000 | 5 (7.2) | 8 (10.4) | 0.506 | 2 (3.4) | 3 (7.7) | 0.384 | |
TFTs, thyroid function tests; GCG, patients treated with glucocorticoids; NGCG, patients not treated with glucocorticoids; N, upper limit of the norm.
Values were calculated for patients with relevant data available.